Showing results (71-80 of 239) with videos related to

Sort By:
Pageof 24
Experimental and Molecular Pathology|August 17, 2013
Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomyKatharina Grupp, Thorsten Simon Höhne, Kristina Prien, et al.
Oncotarget|March 13, 2015
Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancerChristoph Burdelski, Christian Strauss, Maria Christina Tsourlakis, et al.
BMC Cancer|November 14, 2018
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcomeKatharina Grupp, Bianca Hofmann, Asad Kutup, et al.
International Journal of Cancer|May 27, 2015
Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancerMartina Kluth, Frederic Runte, Philipp Barow, et al.
Plos One|June 2, 2015
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate CancersChristoph Burdelski, Erzen Bujupi, Maria Christina Tsourlakis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2013
Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusionsMartina Kluth, Jana Hesse, Anna Heinl, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomyKatharina Grupp, Mareike Habermann, Hüseyin Sirma, et al.
Oncology Letters|October 19, 2018
High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastasesFranziska Brandi, Katharina Grupp, Claudia Hube-Magg, et al.
The Journal of Pathology|June 25, 2013
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancersAntje Krohn, Annemarie Seidel, Lia Burkhardt, et al.
The Prostate|January 15, 2016
Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancerNathaniel Melling, Berivan Taskin, Claudia Hube-Magg, et al.
Pageof 24